FUJIFILM Group, publicly owned and headquartered in Japan, was founded in 1934 and employs approximately 72,260 individuals. The company reported $22.5B in revenue as of 2025. As a manufacturing entity, FUJIFILM Group provides products and services across multiple sectors, including Healthcare, encompassing Medical Systems, Bio-CDMO, and LS Solutions. Its Electronics division focuses on Semiconductor Materials, Display Materials, and Other Electronics Materials. Through its Business Innovation segment, it delivers Business Solutions, Office Solutions, and Graphic Communications. Additionally, the company operates in the Imaging sector, covering both Consumer Imaging and Professional Imaging.
On June 25, 2026, Nazdar acquired Fujifilm’s screen and flexographic ink business for the U.S., Canada, and Latin America markets through a sale and licensing arrangement. Earlier on the same day, Fujifilm unveiled its new Revoria Press PC2120 in North America during the company's "Make More" event near Chicago. Previously, on June 23, the Unified Patent Court (UPC) Court of Appeal issued a landmark decision in the Fujifilm v Kodak case, which clarified the extent of the UPC's jurisdiction over EP designations outside its Member States in European patent litigation. This followed Fujifilm Healthcare Americas opening an 18,000-square-foot endoscopy warehouse facility in Fairfield, N.J., on June 19, an investment designed to support its expanding operational and logistics needs for its endoscopy business. Also on June 19, Fujifilm's Life Sciences group announced it would showcase its integrated global ecosystem, aimed at accelerating the path from discovery to delivery for biopharmaceutical innovators, at the BIO International Convention 2026.
Subscribe for full access to FUJIFILM Group's products in full detail
Subscribe for full access to FUJIFILM Group's revenue in full detail
Subscribe for full access to FUJIFILM Group's products in full detail 
